SEARCH:   Advanced

Blood, 15 October 2006, Vol. 108, No. 8, pp. 2554-2561. Prepublished online as a Blood First Edition Paper on June 20, 2006; DOI 10.1182/blood-2006-04-008532. This Article Full Text Full Text (PDF) All Versions of this Article: blood-2006-04-008532v1 108/8/2554    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Parker, A. L. Articles by Baker, A. H. Search for Related Content PubMed PubMed Citation Articles by Parker, A. L. Articles by Baker, A. H. Related Collections Hemostasis, Thrombosis, and Vascular Biology Gene Therapy Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  GENE THERAPY Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes Alan L. Parker, Simon N. Waddington, Campbell G. Nicol, Dmitry M. Shayakhmetov, Suzanne M. Buckley, Laura Denby, Geoffrey Kemball-Cook, Shaoheng Ni, Andre Lieber, John H. McVey, Stuart A. Nicklin, and Andrew H. Baker From the British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, United Kingdom; Imperial College London, Gene Therapy Research Group, United Kingdom; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle; and Haemostasis and Thrombosis, Medical Research Council (MRC) Clinical Sciences Centre, Imperial College London, United Kingdom. Upon local delivery, adenovirus (Ad) serotype 5 viruses use the coxsackie and Ad receptor (CAR) for cell binding and v integrins for internalization. When administered systemically, however, their role in liver tropism is limited because CAR-permissive and mutated viruses show similar biodistribution, a finding recently attributed to blood coagulation factor (F) IX or complement protein C4BP binding to the adenovirus fiber and "bridging" to either low-density lipoprotein receptor-related protein or heparan sulfate proteoglycans. Here, we show that hepatocyte transduction in vitro can be enhanced by the vitamin K-dependent factors FX, protein C, and FVII in addition to FIX but not by prothrombin (FII), FXI, and FXII. This phenomenon was not dependent on proteolytic activation or cell signaling activity and for FX was mediated by direct virus-factor binding. Human FX substantially enhanced hepatocyte transduction by CAR-permissive and mutated viruses in an ex vivo liver perfusion model. In vivo, global down-regulation of vitamin K-dependent zymogens by warfarin significantly diminished liver uptake of CAR-deleted Ads; however, this phenomenon was fully rescued by acute infusion of human FX. Our results indicate a common and pivotal role for distinct vitamin K-dependent coagulation factors in mediating hepatocyte transduction by adenoviruses in vitro and in vivo. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: J. Skupsky, A.-H. Zhang, Y. Su, and D. W. Scott A role for thrombin in the initiation of the immune response to therapeutic factor VIII Blood, November 19, 2009; 114(21): 4741 - 4748. [Abstract] [Full Text] [PDF] R. Alba, A. C. Bradshaw, A. L. Parker, D. Bhella, S. N. Waddington, S. A. Nicklin, N. van Rooijen, J. Custers, J. Goudsmit, D. H. Barouch, et al. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer Blood, July 30, 2009; 114(5): 965 - 971. [Abstract] [Full Text] [PDF] L. Coughlan, S. Vallath, A. Saha, M. Flak, I. A. McNeish, G. Vassaux, J. F. Marshall, I. R. Hart, and G. J. Thomas In Vivo Retargeting of Adenovirus Type 5 to {alpha}v{beta}6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery J. Virol., July 1, 2009; 83(13): 6416 - 6428. [Abstract] [Full Text] [PDF] O. Granio, M. Porcherot, S. Corjon, K. Kitidee, P. Henning, A. Eljaafari, A. Cimarelli, L. Lindholm, P. Miossec, P. Boulanger, et al. Improved Adenovirus Type 5 Vector-Mediated Transduction of Resistant Cells by Piggybacking on Coxsackie B-Adenovirus Receptor-Pseudotyped Baculovirus J. Virol., June 15, 2009; 83(12): 6048 - 6066. [Abstract] [Full Text] [PDF] M. I. Jonsson, A. E. Lenman, L. Frangsmyr, C. Nyberg, M. Abdullahi, and N. Arnberg Coagulation Factors IX and X Enhance Binding and Infection of Adenovirus Types 5 and 31 in Human Epithelial Cells J. Virol., April 15, 2009; 83(8): 3816 - 3825. [Abstract] [Full Text] [PDF] S. Raman, T.-H. Hsu, S. L. Ashley, and K. R. Spindler Usage of Integrin and Heparan Sulfate as Receptors for Mouse Adenovirus Type 1 J. Virol., April 1, 2009; 83(7): 2831 - 2838. [Abstract] [Full Text] [PDF] R. C. Carlisle, Y. Di, A. M. Cerny, A. F.-P. Sonnen, R. B. Sim, N. K. Green, V. Subr, K. Ulbrich, R. J. C. Gilbert, K. D. Fisher, et al. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1 Blood, February 26, 2009; 113(9): 1909 - 1918. [Abstract] [Full Text] [PDF] A. L. Parker, S. N. Waddington, S. M. K. Buckley, J. Custers, M. J. E. Havenga, N. van Rooijen, J. Goudsmit, J. H. McVey, S. A. Nicklin, and A. H. Baker Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer J. Virol., January 1, 2009; 83(1): 479 - 483. [Abstract] [Full Text] [PDF] Z. Xu, J. Tian, J. S. Smith, and A. P. Byrnes Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement J. Virol., December 1, 2008; 82(23): 11705 - 11713. [Abstract] [Full Text] [PDF] D. Stone, Y. Liu, Z.-Y. Li, R. Strauss, E. E. Finn, J. M. Allen, J. S. Chamberlain, and A. Lieber Biodistribution and Safety Profile of Recombinant Adeno-Associated Virus Serotype 6 Vectors following Intravenous Delivery J. Virol., August 1, 2008; 82(15): 7711 - 7715. [Abstract] [Full Text] [PDF] E. V. Shashkova, K. Doronin, J. S. Senac, and M. A. Barry Macrophage Depletion Combined with Anticoagulant Therapy Increases Therapeutic Window of Systemic Treatment with Oncolytic Adenovirus Cancer Res., July 15, 2008; 68(14): 5896 - 5904. [Abstract] [Full Text] [PDF] O. Kalyuzhniy, N. C. Di Paolo, M. Silvestry, S. E. Hofherr, M. A. Barry, P. L. Stewart, and D. M. Shayakhmetov Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo PNAS, April 8, 2008; 105(14): 5483 - 5488. [Abstract] [Full Text] [PDF] H. Sakurai, K. Tashiro, K. Kawabata, T. Yamaguchi, F. Sakurai, S. Nakagawa, and H. Mizuguchi Adenoviral Expression of Suppressor of Cytokine Signaling-1 Reduces Adenovirus Vector-Induced Innate Immune Responses J. Immunol., April 1, 2008; 180(7): 4931 - 4938. [Abstract] [Full Text] [PDF] N. C. Di Paolo, O. Kalyuzhniy, and D. M. Shayakhmetov Fiber Shaft-Chimeric Adenovirus Vectors Lacking the KKTK Motif Efficiently Infect Liver Cells In Vivo J. Virol., November 15, 2007; 81(22): 12249 - 12259. [Abstract] [Full Text] [PDF] D. Stone, Y. Liu, D. Shayakhmetov, Z.-Y. Li, S. Ni, and A. Lieber Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver J. Virol., May 1, 2007; 81(9): 4866 - 4871. [Abstract] [Full Text] [PDF] A. L. Parker, J. H. McVey, J. H. Doctor, O. Lopez-Franco, S. N. Waddington, M. J. E. Havenga, S. A. Nicklin, and A. H. Baker Influence of Coagulation Factor Zymogens on the Infectivity of Adenoviruses Pseudotyped with Fibers from Subgroup D J. Virol., April 1, 2007; 81(7): 3627 - 3631. [Abstract] [Full Text] [PDF]

	Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020